馬德里加爾製藥公司
US ˙ NasdaqGS ˙ US5588681057

SecurityMDGL / Madrigal Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership29,253 shares
Latest Disclosed Value $ 8,853,127
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 4.52% decrease in ownership of MDGL / Madrigal Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 29,253 shares of Madrigal Pharmaceuticals, Inc. (US:MDGL) valued at $8,853,128 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 30,637 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -4.52% during the quarter. The current value of the position is $14,245,626 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Madrigal Pharmaceuticals EC US5588681057 29,253 -1,384 -4.52 8,853 -12.75 0.1988
2025-05-28 2025-03-31 NP Madrigal Pharmaceuticals EC US5588681057 30,637 325 1.07 10,148 8.49 0.2434
2025-02-25 2024-12-31 NP Madrigal Pharmaceuticals EC US5588681057 30,312 -4,009 -11.68 9,353 28.42 0.2042
2024-11-26 2024-09-30 NP Madrigal Pharmaceuticals EC US5588681057 34,321 6,266 22.33 7,284 -7.33 0.1378
2024-08-26 2024-06-30 NP Madrigal Pharmaceuticals EC US5588681057 28,055 1,933 7.40 7,860 12.67 0.1601
2024-05-28 2024-03-31 NP Madrigal Pharmaceuticals EC US5588681057 26,122 -731 -2.72 6,976 12.26 0.1456
2024-02-26 2023-12-31 NP Madrigal Pharmaceuticals EC US5588681057 26,853 3,761 16.29 6,213 84.25 0.1326
2023-11-28 2023-09-30 NP Madrigal Pharmaceuticals EC US5588681057 23,092 -421 -1.79 3,372 -37.91 0.0880
2023-08-25 2023-06-30 NP Madrigal Pharmaceuticals EC US5588681057 23,513 3,165 15.55 5,432 10.18 0.1288
2023-05-26 2023-03-31 NP Madrigal Pharmaceuticals EC US5588681057 20,348 499 2.51 4,930 -14.44 0.1313
2023-02-24 2022-12-31 NP Madrigal Pharmaceuticals EC US5588681057 19,849 -539 -2.64 5,761 334.79 0.1585
2022-11-25 2022-09-30 NP Madrigal Pharmaceuticals EC US5588681057 20,388 542 2.73 1,325 -6.69 0.0380
2022-08-25 2022-06-30 NP Madrigal Pharmaceuticals EC US5588681057 19,846 1,642 9.02 1,421 -20.49 0.0392
2022-05-26 2022-03-31 NP Madrigal Pharmaceuticals EC US5588681057 18,204 68 0.37 1,786 16.28 0.0416
2022-02-25 2021-12-31 NP Madrigal Pharmaceuticals EC US5588681057 18,136 959 5.58 1,537 12.12 0.0333
2021-11-24 2021-09-30 NP Madrigal Pharmaceuticals EC US5588681057 17,177 0 0.00 1,371 -18.11 0.0302
2021-08-26 2021-06-30 NP Madrigal Pharmaceuticals EC US5588681057 17,177 3,823 28.63 1,673 7.11 0.0359
2021-05-27 2021-03-31 NP Madrigal Pharmaceuticals EC US5588681057 13,354 0 0.00 1,562 5.26 0.0354
2021-02-25 2020-12-31 NP Madrigal Pharmaceuticals EC US5588681057 13,354 -1,322 -9.01 1,485 -14.81 0.0380
2020-11-25 2020-09-30 NP Madrigal Pharmaceuticals EC US5588681057 14,676 0 0.00 1,742 4.81 0.0559
2020-08-27 2020-06-30 NP Madrigal Pharmaceuticals EC US5588681057 14,676 -89 -0.60 1,662 68.73 0.0543
2020-06-01 2020-03-31 NP Madrigal Pharmaceuticals EC US5588681057 14,765 2,672 22.10 986 -10.54 0.0403
2020-02-27 2019-12-31 NP Madrigal Pharmaceuticals EC 558868105 12,093 169 1.42 1,102 7.10 0.0331
2019-11-27 2019-09-30 NP Madrigal Pharmaceuticals EC US5588681057 11,924 11,924 1,028 0.0340
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.